MACQUARIE GROUP LTD - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$31,000
+47.6%
6,996
-5.8%
0.00%
Q2 2022$21,000
-50.0%
7,4230.0%0.00%
Q1 2022$42,000
-38.2%
7,4230.0%0.00%
Q4 2021$68,000
-32.0%
7,423
-20.4%
0.00%
Q3 2021$100,000
+61.3%
9,321
+131.6%
0.00%
Q2 2021$62,000
-4.6%
4,0250.0%0.00%
Q1 2021$65,000
-40.4%
4,025
-21.5%
0.00%
Q4 2020$109,000
+43.4%
5,1270.0%0.00%
Q3 2020$76,000
+18.8%
5,127
+18.5%
0.00%
Q2 2020$64,0004,3270.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders